98 related articles for article (PubMed ID: 17137327)
1. Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma.
Sung FL; Pang RT; Ma BB; Lee MM; Chow SM; Poon TC; Chan AT
J Proteome Res; 2006 Dec; 5(12):3260-7. PubMed ID: 17137327
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells.
Sung FL; Poon TC; Hui EP; Ma BB; Liong E; To KF; Huang DP; Chan AT
In Vivo; 2005; 19(1):237-45. PubMed ID: 15796181
[TBL] [Abstract][Full Text] [Related]
3. Identification of the amyloid β-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics.
Tang CE; Guan YJ; Yi B; Li XH; Liang K; Zou HY; Yi H; Li MY; Zhang PF; Li C; Peng F; Chen ZC; Yao KT; Xiao ZQ
J Proteome Res; 2010 Dec; 9(12):6101-11. PubMed ID: 20882990
[TBL] [Abstract][Full Text] [Related]
4. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis.
Chen Y; Ouyang GL; Yi H; Li MY; Zhang PF; Li C; Li JL; Liu YF; Chen ZC; Xiao ZQ
J Proteome Res; 2008 Dec; 7(12):5254-62. PubMed ID: 19367706
[TBL] [Abstract][Full Text] [Related]
5. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
[TBL] [Abstract][Full Text] [Related]
6. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS
Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867
[TBL] [Abstract][Full Text] [Related]
7. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
8. [Identification of down-regulated expressed sequence tag at chromosome 3p21 in nasopharyngeal carcinoma].
He XS; Chen ZC; Tian F; Xiao ZQ; He ZM; Guan YJ; Li F; He CM; Yuan JH
Ai Zheng; 2003 Jan; 22(1):1-5. PubMed ID: 12561426
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.
Skvortsova I; Skvortsov S; Raju U; Stasyk T; Riesterer O; Schottdorf EM; Popper BA; Schiestl B; Eichberger P; Debbage P; Neher A; Bonn GK; Huber LA; Milas L; Lukas P
Radiother Oncol; 2010 Jul; 96(1):108-15. PubMed ID: 20451273
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells.
Fang HY; Chen SB; Guo DJ; Pan SY; Yu ZL
Phytomedicine; 2011 Jun; 18(8-9):697-703. PubMed ID: 21239154
[TBL] [Abstract][Full Text] [Related]
11. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
[TBL] [Abstract][Full Text] [Related]
12. Identification of Galectin-1 as a novel biomarker in nasopharyngeal carcinoma by proteomic analysis.
Tang CE; Tan T; Li C; Chen ZC; Ruan L; Wang HH; Su T; Zhang PF; Xiao ZQ
Oncol Rep; 2010 Aug; 24(2):495-500. PubMed ID: 20596638
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of tumor suppressor gene maspin in breast cancer.
Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
[TBL] [Abstract][Full Text] [Related]
14. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft.
Luo FR; Yang Z; Dong H; Camuso A; McGlinchey K; Fager K; Flefleh C; Kan D; Inigo I; Castaneda S; Rose WC; Kramer RA; Wild R; Lee FY
Cancer Chemother Pharmacol; 2005 Nov; 56(5):455-64. PubMed ID: 15947929
[TBL] [Abstract][Full Text] [Related]
15. [Screening proteins related to retinoic acid resistance by proteomic analysis].
Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
[TBL] [Abstract][Full Text] [Related]
16. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.
Schedel J; Distler O; Woenckhaus M; Gay RE; Simmen B; Michel BA; Müller-Ladner U; Gay S
Ann Rheum Dis; 2004 Oct; 63(10):1205-11. PubMed ID: 15361372
[TBL] [Abstract][Full Text] [Related]
17. Proteomics-based identification of proteins with altered expression induced by 12-O-tetradecanoylphorbol 13-acetate in nasopharyngeal carcinoma CNE2 cells.
Jiang PZ; Gan M; Huang H; Shen XM; Wang S; Yao KT
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):97-106. PubMed ID: 15685366
[TBL] [Abstract][Full Text] [Related]
18. IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression.
Kuo YS; Tang YB; Lu TY; Wu HC; Lin CT
J Pathol; 2010 Nov; 222(3):299-309. PubMed ID: 20635349
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Li Z; Ren Y; Wu QC; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Jan; 117(1):107-14. PubMed ID: 14733785
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]